Company Filing History:
Years Active: 2009
Title: Harel Rosen: Innovator in Pharmaceutical Formulations
Introduction
Harel Rosen, based in Raanana, Israel, is a notable inventor with a focus on pharmaceutical innovations. With two patents to his name, he has made significant contributions to the field, particularly through his work on Rasagiline formulations. His dedication to pharmaceutical advancements demonstrates his commitment to enhancing medical treatments.
Latest Patents
Harel Rosen's latest inventions revolve around novel Rasagiline formulations and processes for their preparation. The primary patent outlines a pharmaceutical composition that includes N-propargyl-1(R)-aminoindan mesylate combined with a pharmaceutically acceptable carrier. It specifies that the formulation contains greater than 0.7 ppm but less than 30 ppm of a particular compound and any of its salts. This innovative approach is poised to improve the efficacy of Rasagiline, a drug commonly used in the treatment of Parkinson's disease.
Career Highlights
Harel Rosen is currently employed at Teva Pharmaceutical Industries Limited, a leading player in the global pharmaceutical market. His role at Teva has allowed him to leverage his expertise in drug formulation and development, contributing to the advancement of therapeutic solutions. Over the years, he has garnered respect and recognition within the scientific community for his dedication to pharmaceutical innovation.
Collaborations
Throughout his career, Harel has had the opportunity to collaborate with esteemed colleagues, including Jeffrey Sterling and David Lerner. These partnerships highlight the importance of teamwork in driving innovation within the pharmaceutical sector, as collective expertise often leads to breakthroughs in drug formulation and delivery.
Conclusion
Harel Rosen exemplifies the spirit of innovation within the pharmaceutical industry. His work on Rasagiline formulations showcases his commitment to advancing medical science and improving patient outcomes. As he continues to collaborate with fellow inventors and researchers, Harel remains a significant figure in the field of pharmaceutical inventions. His contributions are likely to have a lasting impact on the development of future therapeutic solutions.